Skip to content

Eikon Therapeutics, Inc. EIKN Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Lockheed Martin logo
Lockheed MartinLMT
$6.93B-19.0%
CHE
ChemedCHE
$9.9M+22.2%
Steven Madden logo
Steven MaddenSHOO
$111.65M+23.3%
UL Solutions logo
UL SolutionsULS
$93M-24.4%
Celcuity logo
CelcuityCELC
$100K
Fidelity National Information Services logo
Fidelity National Information ServicesFIS
$7.04B+50.0%

Other financials

Income statement

See full
Operating income-$87.3M-22.3%
Net income-$83.0M-21.6%
EPS (diluted)-$2.46+90.9%

Balance sheet

See full
Cash & equivalents$161.2M-21.2%
Total debt$254.8M
Total equity$550.7M+186%
Total assets$850.8M

Cash flow

See full
Operating cash flow-$89.8M-64.7%
CapEx$262.0K-98.8%
Free cash flow-$90.1M-17.1%

Valuation

See full
Market cap$521.35M

Where this comes from

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eikon Therapeutics, Inc. 's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eikon Therapeutics, Inc. 's software and technology licenses, net?
Eikon Therapeutics, Inc. (EIKN) reported software and technology licenses, net of $556K in Q1 2026.